首頁 > 市場調查報告書 > 醫療設備

呼吸器

市場調查報告書

商品編碼

1665346

膜氧合器市場機會、成長動力、產業趨勢分析與 2025 - 2034 年預測

Membrane Oxygenators Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2024年12月23日 | 出版商:

Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球膜氧合器市場價值為 1.321 億美元，預計 2025 年至 2034 年期間的複合年成長率為 2.2%。膜氧合器在生命維持中發揮著至關重要的作用，尤其是在重症監護情況下。此外，全球人口老化更容易受到這些情況的影響，這進一步加速了市場擴張。中空纖維膜等技術創新正在提高氣體交換效率並促進整個醫療保健領域的採用。

從類型來看，中空纖維膜氧合器是高成長領域。預計該領域的複合年成長率為 2.6%，到 2034 年將產生 1.006 億美元的收入。這些氧合器以其高效的氣體交換和緊湊的設計而聞名，特別適合緊急情況下的體外膜氧合 (ECMO) 程序。它們適用於成人和兒科護理環境，鞏固了其市場主導地位。

市場範圍
起始年份	2024
預測年份	2025-2034
起始值	1.321億美元
預測值	1.628 億美元
複合年成長率	2.2%

在應用方面，呼吸系統領域持續展現出強勁的潛力，預計到 2034 年將達到 7,250 萬美元，複合年成長率為 1.9%。慢性阻塞性肺病（COPD）和肺炎等呼吸系統疾病的發生率不斷上升是需求的主要促進因素。人口老化、空氣污染水平不斷升級以及菸草廣泛使用等因素導致全球呼吸系統併發症增加，從而增加了對 ECMO 治療和膜式氧合器的需求。

美國膜式氧合器市值在 2024 年將達到 4,420 萬美元，預計到 2034 年將以 1.4% 的複合年成長率成長。人口老化加劇了慢性疾病的發生，進一步增加了對 ECMO 治療的需求。攜帶式和高性能氧合器的創新，加上新生兒和兒科護理中先進生命維持系統的日益普及，是推動區域成長的其他因素。

產業生態系統分析
產業衝擊力
- 成長動力
  - 心血管疾病盛行率上升
  - 體外膜氧合（ECMO）需求不斷成長
  - 急性呼吸窘迫症候群（ARDS）發生率高
  - 器官移植手術增多
  - 兒科和新生兒護理應用激增
- 產業陷阱與挑戰
  - 嚴格的監管要求
  - 先進氧合器成本高
成長潛力分析
監管格局
技術格局
差距分析
波特的分析
PESTEL 分析
未來市場趨勢
價值鏈分析
體外膜氧合器（ECMO）的演變
人工智慧預測 ECMO 支持患者出血情況

第4章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
主要市場參與者的競爭分析
競爭定位矩陣
策略儀表板

第5章：市場估計與預測：按類型，2021 — 2034 年

主要趨勢
中空纖維膜氧合器
平板膜氧合器

第6章：市場估計與預測：按應用，2021 — 2034 年

主要趨勢
呼吸系統
- 呼吸衰竭
- 肺栓塞
- 急性呼吸窘迫症候群
- 肺炎
- 新冠肺炎
心臟
- 失代償性心肌病變
- 急性心肌梗塞
- 心臟休克
- 移植後併發症
- 心肌炎
體外心肺復甦

第7章：市場估計與預測：依年齡段，2021 年至 2034 年

主要趨勢
成年人
新生兒
兒科

第 8 章：市場估計與預測：依最終用途，2021 年至 2034 年

主要趨勢
醫院
門診手術中心
其他最終用戶

第9章：市場估計與預測：按地區，2021 年至 2034 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第10章：公司簡介

Abbott
BRAILE
chalice
CytoSorbents
EUROSETS
Fresenius
GETINGE
LivaNova
Medtronic
MicroPort
NIPRO
PrecisionMedical
RECTUS MEDICAl
TERUMO
XENIOS

簡介目錄

Product Code: 12827

The Global Membrane Oxygenators Market, valued at USD 132.1 million in 2024, is poised for steady growth with a projected CAGR of 2.2% between 2025 and 2034. This growth is driven by the rising prevalence of respiratory and cardiac disorders, including acute respiratory distress syndrome (ARDS), cardiogenic shock, and myocarditis, which are fueling demand for advanced oxygenation systems. Membrane oxygenators play a vital role in life support, especially in critical care scenarios. Additionally, the aging global population, which is more vulnerable to these conditions, further accelerates market expansion. Technological innovations, such as the adoption of hollow fiber membranes, are enhancing gas exchange efficiency and boosting adoption across healthcare settings.

By type, hollow fiber membrane oxygenators stand out as a high-growth segment. Expected to grow at a CAGR of 2.6%, this segment is anticipated to generate USD 100.6 million by 2034. Known for their efficiency in gas exchange and compact design, these oxygenators are particularly suited for extracorporeal membrane oxygenation (ECMO) procedures in emergency situations. Their adaptability for use in both adult and pediatric care settings cements their market dominance.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$132.1 Million
Forecast Value	$162.8 Million
CAGR	2.2%

In terms of application, the respiratory segment continues to demonstrate strong potential, projected to reach USD 72.5 million by 2034 with a CAGR of 1.9%. The increasing incidence of respiratory conditions such as chronic obstructive pulmonary disease (COPD) and pneumonia is a key driver of demand. Factors like aging populations, escalating air pollution levels, and widespread tobacco use are contributing to a global rise in respiratory complications, heightening the need for ECMO therapy and membrane oxygenators.

The U.S. membrane oxygenators market, valued at USD 44.2 million in 2024, is expected to grow at a CAGR of 1.4% through 2034. The country's robust healthcare infrastructure and high prevalence of respiratory and cardiovascular diseases make it a significant contributor to market expansion. An aging population prone to chronic health conditions further bolsters demand for ECMO treatments. Innovations in portable and high-performance oxygenators, coupled with increasing adoption of advanced life-support systems in neonatal and pediatric care, are additional factors driving regional growth.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising cardiovascular disease prevalence
  - 3.2.1.2 Growing demand for extracorporeal membrane oxygenation (ECMO)
  - 3.2.1.3 High incidence of acute respiratory distress syndrome (ARDS)
  - 3.2.1.4 Rise in organ transplant procedures
  - 3.2.1.5 Surging application in pediatric and neonatal care
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Strict regulatory requirements
  - 3.2.2.2 High costs of advanced oxygenators
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Gap analysis
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Future market trends
3.10 Value chain analysis
3.11 Evolution of extracorporeal membrane oxygenators (ECMO)
3.12 AI-enabled prediction of bleeding in patients supported on ECMO

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 — 2034 ($ Mn)

5.1 Key trends
5.2 Hollow fiber membrane oxygenators
5.3 Flat sheet membrane oxygenators

Chapter 6 Market Estimates and Forecast, By Application, 2021 — 2034 ($ Mn)

6.1 Key trends
6.2 Respiratory
- 6.2.1 Respiratory failure
- 6.2.2 Pulmonary embolism
- 6.2.3 Acute respiratory distress syndrome
- 6.2.4 Pneumonia
- 6.2.5 COVID-19
6.3 Cardiac
- 6.3.1 Decompensated cardiomyopathy
- 6.3.2 Acute myocardial infarction
- 6.3.3 Cardiogenic shock
- 6.3.4 Post-transplant complications
- 6.3.5 Myocarditis
6.4 Extra corporeal cardiopulmonary resuscitation

Chapter 7 Market Estimates and Forecast, By Age Group, 2021 — 2034 ($ Mn)

7.1 Key trends
7.2 Adults
7.3 Neonates
7.4 Pediatrics

Chapter 8 Market Estimates and Forecast, By End Use, 2021 — 2034 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Ambulatory surgical centers
8.4 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 — 2034 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE